246 related articles for article (PubMed ID: 22565785)
1. Genetic variability of drug-metabolizing enzymes: the dual impact on psychiatric therapy and regulation of brain function.
Stingl JC; Brockmöller J; Viviani R
Mol Psychiatry; 2013 Mar; 18(3):273-87. PubMed ID: 22565785
[TBL] [Abstract][Full Text] [Related]
2. [Genetic polymorphisms on drug metabolizing enzymes in relation to anti-cancer drug effectiveness].
Ozawa S
Rinsho Byori; 2003 Feb; 51(2):168-73. PubMed ID: 12690635
[TBL] [Abstract][Full Text] [Related]
3. Pharmacogenomics of drug-metabolizing enzymes: a recent update on clinical implications and endogenous effects.
Sim SC; Kacevska M; Ingelman-Sundberg M
Pharmacogenomics J; 2013 Feb; 13(1):1-11. PubMed ID: 23089672
[TBL] [Abstract][Full Text] [Related]
4. [Pharmacogenetics/pharmacogenomics in psychiatry].
Ueda M; Ishiguro S; Watanabe T; Saeki Y; Shimoda K
Nihon Rinsho; 2010 Jan; 68(1):155-62. PubMed ID: 20077810
[TBL] [Abstract][Full Text] [Related]
5. Personalized medicine in psychiatry: new technologies and approaches.
Costa e Silva JA
Metabolism; 2013 Jan; 62 Suppl 1():S40-4. PubMed ID: 23018148
[TBL] [Abstract][Full Text] [Related]
6. Pharmacogenetics and drug therapy in psychiatry--the role of the CYP2D6 polymorphism.
Vandel P; Talon JM; Haffen E; Sechter D
Curr Pharm Des; 2007; 13(2):241-50. PubMed ID: 17269931
[TBL] [Abstract][Full Text] [Related]
7. CYP2D6 variation, behaviour and psychopathology: implications for pharmacogenomics-guided clinical trials.
Peñas-Lledó EM; Llerena A
Br J Clin Pharmacol; 2014 Apr; 77(4):673-83. PubMed ID: 24033670
[TBL] [Abstract][Full Text] [Related]
8. The clinical role of genetic polymorphisms in drug-metabolizing enzymes.
Tomalik-Scharte D; Lazar A; Fuhr U; Kirchheiner J
Pharmacogenomics J; 2008 Feb; 8(1):4-15. PubMed ID: 17549068
[TBL] [Abstract][Full Text] [Related]
9. [State of the art of pharmacogenetic diagnostics in drug therapy].
Kirchheiner J; Seeringer A; Brockmöller J
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2006 Oct; 49(10):995-1003. PubMed ID: 17013776
[TBL] [Abstract][Full Text] [Related]
10. [Clinical significance of pharmacogenetics in psychiatry].
Skrętkowicz J; Barańska M; Rychlik-Sych M
Wiad Lek; 2013; 66(2 Pt 2):185-91. PubMed ID: 25775815
[TBL] [Abstract][Full Text] [Related]
11. Pharmacogenetics in cancer treatment.
Nagasubramanian R; Innocenti F; Ratain MJ
Annu Rev Med; 2003; 54():437-52. PubMed ID: 12525681
[TBL] [Abstract][Full Text] [Related]
12. Pharmacogenetics of analgesics: toward the individualization of prescription.
Rollason V; Samer C; Piguet V; Dayer P; Desmeules J
Pharmacogenomics; 2008 Jul; 9(7):905-33. PubMed ID: 18597654
[TBL] [Abstract][Full Text] [Related]
13. Developmental pharmacology.
van den Anker JN
Dev Disabil Res Rev; 2010; 16(3):233-8. PubMed ID: 20981761
[TBL] [Abstract][Full Text] [Related]
14. Polymorphism of human cytochrome P450 enzymes and its clinical impact.
Zhou SF; Liu JP; Chowbay B
Drug Metab Rev; 2009; 41(2):89-295. PubMed ID: 19514967
[TBL] [Abstract][Full Text] [Related]
15. Pharmacogenetics in psychiatry--a useful clinical tool or wishful thinking for the future?
Kirchheiner J; Seeringer A; Viviani R
Curr Pharm Des; 2010; 16(2):136-44. PubMed ID: 20205659
[TBL] [Abstract][Full Text] [Related]
16. Pharmacogenetics of P450 oxidoreductase: implications in drug metabolism and therapy.
Hu L; Zhuo W; He YJ; Zhou HH; Fan L
Pharmacogenet Genomics; 2012 Nov; 22(11):812-9. PubMed ID: 23047293
[TBL] [Abstract][Full Text] [Related]
17. Personalized pharmacotherapy in psychiatry.
Filaković P; Petek A
Psychiatr Danub; 2009 Sep; 21(3):341-6. PubMed ID: 19794353
[TBL] [Abstract][Full Text] [Related]
18. Pharmacogenetics of neurological and psychiatric diseases at older age: has the time come?
Lozupone M; Panza F; Stella E; La Montagna M; Bisceglia P; Miscio G; Galizia I; Daniele A; di Mauro L; Bellomo A; Logroscino G; Greco A; Seripa D
Expert Opin Drug Metab Toxicol; 2017 Mar; 13(3):259-277. PubMed ID: 27718745
[TBL] [Abstract][Full Text] [Related]
19. Pharmacogenetics and psychoactive drug therapy: ready for the patient?
Steimer W
Ther Drug Monit; 2010 Aug; 32(4):381-6. PubMed ID: 20526233
[TBL] [Abstract][Full Text] [Related]
20. CYP2D6 genotyping for psychiatric patients treated with risperidone: considerations for cost-effectiveness studies.
Rodríguez-Antona C; Gurwitz D; de Leon J; Llerena A; Kirchheiner J; de Mesa EG; Ibarreta D
Pharmacogenomics; 2009 Apr; 10(4):685-99. PubMed ID: 19374522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
